Chargement en cours...
Venetoclax-based Therapies for Acute Myeloid Leukemia
The prognosis of adult acute myeloid leukemia (AML) remains poor, with the long-term survival rate less than 50%. However, the current paradigms of treatment are changing through a better understanding of the disease genetics and pathophysiology. Since 2017, eight new drugs have been approved by the...
Enregistré dans:
| Publié dans: | Best Pract Res Clin Haematol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581210/ https://ncbi.nlm.nih.gov/pubmed/31203996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2019.05.008 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|